433 related articles for article (PubMed ID: 33032646)
1. Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N.
Bono K; Hara-Miyauchi C; Sumi S; Oka H; Iguchi Y; Okano HJ
Mol Brain; 2020 Oct; 13(1):137. PubMed ID: 33032646
[TBL] [Abstract][Full Text] [Related]
2. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration.
Tsika E; Glauser L; Moser R; Fiser A; Daniel G; Sheerin UM; Lees A; Troncoso JC; Lewis PA; Bandopadhyay R; Schneider BL; Moore DJ
Hum Mol Genet; 2014 Sep; 23(17):4621-38. PubMed ID: 24740878
[TBL] [Abstract][Full Text] [Related]
4. The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer.
Follett J; Norwood SJ; Hamilton NA; Mohan M; Kovtun O; Tay S; Zhe Y; Wood SA; Mellick GD; Silburn PA; Collins BM; Bugarcic A; Teasdale RD
Traffic; 2014 Feb; 15(2):230-44. PubMed ID: 24152121
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease-linked
Chen X; Kordich JK; Williams ET; Levine N; Cole-Strauss A; Marshall L; Labrie V; Ma J; Lipton JW; Moore DJ
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5765-5774. PubMed ID: 30842285
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial and Clearance Impairment in p.D620N VPS35 Patient-Derived Neurons.
Hanss Z; Larsen SB; Antony P; Mencke P; Massart F; Jarazo J; Schwamborn JC; Barbuti PA; Mellick GD; Krüger R
Mov Disord; 2021 Mar; 36(3):704-715. PubMed ID: 33142012
[TBL] [Abstract][Full Text] [Related]
7. Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition.
Kadgien CA; Kamesh A; Milnerwood AJ
Mol Brain; 2021 Sep; 14(1):143. PubMed ID: 34530877
[TBL] [Abstract][Full Text] [Related]
8. Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting.
Williams ET; Glauser L; Tsika E; Jiang H; Islam S; Moore DJ
Hum Mol Genet; 2018 Sep; 27(18):3189-3205. PubMed ID: 29893854
[TBL] [Abstract][Full Text] [Related]
9. VPS35 D620N knockin mice recapitulate cardinal features of Parkinson's disease.
Niu M; Zhao F; Bondelid K; Siedlak SL; Torres S; Fujioka H; Wang W; Liu J; Zhu X
Aging Cell; 2021 May; 20(5):e13347. PubMed ID: 33745227
[TBL] [Abstract][Full Text] [Related]
10. VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function.
Tang FL; Liu W; Hu JX; Erion JR; Ye J; Mei L; Xiong WC
Cell Rep; 2015 Sep; 12(10):1631-43. PubMed ID: 26321632
[TBL] [Abstract][Full Text] [Related]
11. Formation of retromer transport carriers is disrupted by the Parkinson disease-linked Vps35 D620N variant.
Cui Y; Yang Z; Flores-Rodriguez N; Follett J; Ariotti N; Wall AA; Parton RG; Teasdale RD
Traffic; 2021 Apr; 22(4):123-136. PubMed ID: 33347683
[TBL] [Abstract][Full Text] [Related]
12. VPS35 and retromer dysfunction in Parkinson's disease.
Rowlands J; Moore DJ
Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220384. PubMed ID: 38368930
[TBL] [Abstract][Full Text] [Related]
13. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
[TBL] [Abstract][Full Text] [Related]
14. Role of the VPS35 D620N mutation in Parkinson's disease.
Mohan M; Mellick GD
Parkinsonism Relat Disord; 2017 Mar; 36():10-18. PubMed ID: 27964832
[TBL] [Abstract][Full Text] [Related]
15. VPS35 regulates cell surface recycling and signaling of dopamine receptor D1.
Wang C; Niu M; Zhou Z; Zheng X; Zhang L; Tian Y; Yu X; Bu G; Xu H; Ma Q; Zhang YW
Neurobiol Aging; 2016 Oct; 46():22-31. PubMed ID: 27460146
[TBL] [Abstract][Full Text] [Related]
16. VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.
Chen X; Tsika E; Levine N; Moore DJ
Mol Neurodegener; 2023 Aug; 18(1):51. PubMed ID: 37542299
[TBL] [Abstract][Full Text] [Related]
17. The Role of VPS35 in the Pathobiology of Parkinson's Disease.
Sassone J; Reale C; Dati G; Regoni M; Pellecchia MT; Garavaglia B
Cell Mol Neurobiol; 2021 Mar; 41(2):199-227. PubMed ID: 32323152
[TBL] [Abstract][Full Text] [Related]
18. The impact of VPS35 D620N mutation on alternative autophagy and its reversal by estrogen in Parkinson's disease.
Shiraishi T; Bono K; Hiraki H; Manome Y; Oka H; Iguchi Y; Okano HJ
Cell Mol Life Sci; 2024 Feb; 81(1):103. PubMed ID: 38409392
[TBL] [Abstract][Full Text] [Related]
19. Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy.
Zavodszky E; Seaman MN; Moreau K; Jimenez-Sanchez M; Breusegem SY; Harbour ME; Rubinsztein DC
Nat Commun; 2014 May; 5():3828. PubMed ID: 24819384
[TBL] [Abstract][Full Text] [Related]
20. Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation.
McGough IJ; Steinberg F; Jia D; Barbuti PA; McMillan KJ; Heesom KJ; Whone AL; Caldwell MA; Billadeau DD; Rosen MK; Cullen PJ
Curr Biol; 2014 Jul; 24(14):1670-1676. PubMed ID: 24980502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
